vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是DYNAVAX TECHNOLOGIES CORP的1.7倍（$162.6M vs $94.9M），Ribbon Communications Inc.净利率更高（54.8% vs 28.4%，领先26.4%），DYNAVAX TECHNOLOGIES CORP同比增速更快（17.7% vs -10.3%），过去两年DYNAVAX TECHNOLOGIES CORP的营收复合增速更高（30.6% vs -8.1%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
DVAX vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.7倍
$94.9M
营收增速更快
DVAX
高出28.0%
-10.3%
净利率更高
RBBN
高出26.4%
28.4%
两年增速更快
DVAX
近两年复合增速
-8.1%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $162.6M |
| 净利润 | $26.9M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | 22.4% | 37.6% |
| 净利率 | 28.4% | 54.8% |
| 营收同比 | 17.7% | -10.3% |
| 净利润同比 | 53.0% | — |
| 每股收益（稀释后） | $0.21 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | — | $227.3M | ||
| Q3 25 | $94.9M | $215.4M | ||
| Q2 25 | $95.4M | $220.6M | ||
| Q1 25 | $68.2M | $181.3M | ||
| Q4 24 | $72.0M | $251.4M | ||
| Q3 24 | $80.6M | $210.2M | ||
| Q2 24 | $73.8M | $192.6M |
净利润DVAXRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | — | — | ||
| Q3 25 | $26.9M | $-12.1M | ||
| Q2 25 | $18.7M | $-11.1M | ||
| Q1 25 | $-96.1M | $-26.2M | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $17.6M | $-13.4M | ||
| Q2 24 | $11.4M | $-16.8M |
毛利率DVAXRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率DVAXRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | 22.4% | 1.3% | ||
| Q2 25 | 15.1% | 1.9% | ||
| Q1 25 | -34.7% | -10.8% | ||
| Q4 24 | -2.3% | 13.2% | ||
| Q3 24 | 12.5% | -0.4% | ||
| Q2 24 | 7.0% | -1.0% |
净利率DVAXRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | 28.4% | -5.6% | ||
| Q2 25 | 19.6% | -5.0% | ||
| Q1 25 | -141.0% | -14.5% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 21.8% | -6.4% | ||
| Q2 24 | 15.4% | -8.7% |
每股收益（稀释后）DVAXRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | — | $0.50 | ||
| Q3 25 | $0.21 | $-0.07 | ||
| Q2 25 | $0.14 | $-0.06 | ||
| Q1 25 | $-0.77 | $-0.15 | ||
| Q4 24 | $0.07 | $0.05 | ||
| Q3 24 | $0.12 | $-0.08 | ||
| Q2 24 | $0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $534.1M | $419.1M |
| 总资产 | $946.5M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DVAXRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | — | $96.4M | ||
| Q3 25 | $160.2M | $74.8M | ||
| Q2 25 | $99.1M | $60.5M | ||
| Q1 25 | $51.7M | $71.2M | ||
| Q4 24 | $95.9M | $87.8M | ||
| Q3 24 | $119.3M | $37.2M | ||
| Q2 24 | $112.5M | $64.6M |
总债务DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益DVAXRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | — | $449.0M | ||
| Q3 25 | $534.1M | $360.1M | ||
| Q2 25 | $494.2M | $370.4M | ||
| Q1 25 | $530.9M | $381.8M | ||
| Q4 24 | $596.8M | $404.6M | ||
| Q3 24 | $681.4M | $395.5M | ||
| Q2 24 | $642.8M | $405.0M |
总资产DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $946.5M | $1.1B | ||
| Q2 25 | $918.4M | $1.1B | ||
| Q1 25 | $945.9M | $1.1B | ||
| Q4 24 | $986.3M | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.0B | $1.1B |
负债/权益比DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | — |
| 自由现金流经营现金流 - 资本支出 | $32.6M | — |
| 自由现金流率自由现金流/营收 | 34.4% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $80.5M | — |
8季度趋势，按日历期对齐
经营现金流DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $29.2M | ||
| Q3 25 | $33.8M | $26.5M | ||
| Q2 25 | $23.4M | $-795.0K | ||
| Q1 25 | $-19.6M | $-3.5M | ||
| Q4 24 | $53.0M | $61.8M | ||
| Q3 24 | $19.5M | $-14.8M | ||
| Q2 24 | $10.7M | $-9.8M |
自由现金流DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $27.3M | ||
| Q3 25 | $32.6M | $21.0M | ||
| Q2 25 | $22.0M | $-6.5M | ||
| Q1 25 | $-23.6M | $-15.7M | ||
| Q4 24 | $49.5M | $53.8M | ||
| Q3 24 | $18.1M | $-23.7M | ||
| Q2 24 | $9.9M | $-12.9M |
自由现金流率DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | 34.4% | 9.7% | ||
| Q2 25 | 23.0% | -2.9% | ||
| Q1 25 | -34.6% | -8.7% | ||
| Q4 24 | 68.8% | 21.4% | ||
| Q3 24 | 22.5% | -11.3% | ||
| Q2 24 | 13.5% | -6.7% |
资本支出强度DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.5% | 2.6% | ||
| Q1 25 | 5.8% | 6.7% | ||
| Q4 24 | 4.8% | 3.2% | ||
| Q3 24 | 1.7% | 4.2% | ||
| Q2 24 | 1.1% | 1.6% |
现金转化率DVAXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
